Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Enstilar indication?

See the DrugPatentWatch profile for Enstilar

What indication is Enstilar (calcipotriol/betamethasone) approved for?

Enstilar (calcipotriol/betamethasone dipropionate) is indicated for the treatment of plaque psoriasis in adults.

What psoriasis type does Enstilar target?

The indication is specifically for plaque psoriasis (the most common form of psoriasis), where treatment is aimed at reducing plaques and associated inflammation.

Who can use Enstilar?

The labeled indication referenced above is for adults.

What’s the usual way Enstilar is used for this indication?

Enstilar is a topical treatment applied to affected psoriatic plaques as directed by the prescribing information for plaque psoriasis.

Sources

  1. DrugPatentWatch.com (Enstilar overview and related documentation): https://www.drugpatentwatch.com/


Other Questions About Enstilar :

Is enstilar a foam for psoriasis?